Viemed Healthcare, Inc. (VMD) Investor Outlook: Exploring A 54% Potential Upside
Viemed Healthcare, Inc. (VMD) is attracting investor attention with its strong growth and a potential upside of 54.39% according to analyst targets. The company, a key player in respiratory healthcare services, has shown robust revenue growth of 24.00% and positive financial indicators despite a lack of traditional P/E or PEG ratios. Analysts are overwhelmingly positive, with two buy ratings and no hold or sell recommendations, suggesting a promising outlook for the stock.
Viemed Healthcare (NASDAQ:VMD) Upgraded at Wall Street Zen
Viemed Healthcare (NASDAQ:VMD) was upgraded by Wall Street Zen from a "buy" to a "strong-buy" rating despite other analysts maintaining a "Hold" consensus. The stock opened at $8.28, up 1.5%, with a market capitalization of $314.8 million and a P/E of 25.09. Institutional investors own 74.24% of the stock, with recent modest inflows from several funds.
Thrivent Financial for Lutherans Sells 1,238,000 Shares of Viemed Healthcare, Inc. $VMD
Thrivent Financial for Lutherans significantly reduced its stake in Viemed Healthcare, Inc. (NASDAQ:VMD) by selling 1,238,000 shares, bringing its total ownership to 384,000 shares, valued at approximately $2.61 million. Despite this reduction, other institutional investors increased their holdings, with overall institutional ownership standing at 74.24%. The article also notes Viemed Healthcare's current market performance, financial metrics, and a "Hold" consensus rating from analysts.
Viemed Healthcare, Inc. (NASDAQ:VMD) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Viemed Healthcare's stock has risen by 35% in three months, but its fundamentals, particularly its 10% Return on Equity (ROE) and five-year net income shrinkage of 17%, present a mixed picture. While the company retains most of its profits, its low ROE and declining earnings suggest that these reinvestments might not be effectively benefiting investors, especially when compared to the industry's 2.9% earnings growth. Analysts, however, anticipate future earnings growth for Viemed Healthcare.
Viemed Healthcare, Inc. (NASDAQ:VMD) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Viemed Healthcare's stock has risen 35% in the past three months, but its fundamentals, particularly its 10% Return on Equity (ROE), appear mixed. Despite reinvesting all profits, the company's net income has shrunk by 17% over five years, contrasting with the industry's 2.9% growth. While current performance is ambiguous, analysts forecast future earnings growth for the company.
Technical Reactions to VMD Trends in Macro Strategies
This article analyzes Viemed Healthcare Inc. (NYSE: VMD) using AI models to provide technical reactions and macro strategies. It identifies a neutral sentiment across all time horizons, suggesting a wait-and-see approach, and outlines specific position trading, momentum breakout, and risk hedging strategies with entry and exit points, targets, and stop losses. The analysis highlights a 32.0:1 risk-reward short setup if resistance holds.
Viemed Healthcare, Inc. (NASDAQ:VMD) is favoured by institutional owners who hold 58% of the company
Institutional investors hold a significant 58% ownership in Viemed Healthcare, Inc. (NASDAQ:VMD), making the company's stock vulnerable to their trading decisions. The top 13 shareholders collectively own 50% of the company, and insiders hold a 13% stake, aligning their interests with shareholders. The article suggests investigating analyst recommendations and revenue growth for further insights into the company's performance.
Trading the Move, Not the Narrative: (VMD) Edition
This article analyzes Viemed Healthcare Inc. (NYSE: VMD) with a neutral sentiment across all time horizons, suggesting a wait-and-see approach. It highlights resistance testing and an exceptional risk-reward short setup targeting 9.0% downside. The analysis provides three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles.
Unveiling US Market's 3 Undiscovered Gems
This article from Simply Wall St identifies three "undiscovered gems" in the US market: Viemed Healthcare (VMD), Here Group (HERE), and Movado Group (MOV). It highlights their fundamental strengths, financial health, and growth prospects, suggesting they offer unique opportunities amidst broader market fluctuations despite some challenges. The analysis aims to help investors look beyond headlines for promising stocks.
Viemed Healthcare (NASDAQ:VMD) Rating Lowered to "Buy" at Wall Street Zen
Viemed Healthcare (NASDAQ:VMD) had its rating downgraded from "strong-buy" to "buy" by Wall Street Zen, while Weiss Ratings reaffirmed a "hold (c)" and analysts on MarketBeat maintain a "Hold" consensus. The company reported quarterly EPS of $0.09, meeting estimates, and revenue of $71.91 million, slightly below expectations. VMD currently trades around $7.24 with a market capitalization of approximately $275 million.
Viemed Healthcare (NASDAQ:VMD) Stock Rating Upgraded by Zacks Research
Zacks Research has upgraded Viemed Healthcare (NASDAQ:VMD) to a "hold" rating, aligning with MarketBeat's consensus. The company recently reported quarterly earnings per share of $0.09, matching estimates, with revenue slightly below expectations at $71.91 million. Viemed Healthcare, which provides home-based respiratory therapy services, has a market capitalization of $275.26 million, and institutional investors own approximately 74.24% of its stock.
Viemed Healthcare Announces Third Quarter 2025 Financial Results
Viemed Healthcare, Inc. (NASDAQ:VMD) announced record financial results for the third quarter of 2025, with net revenues of $71.9 million, a 24% increase year-over-year. The company reported a net income of $3.5 million ($0.09 per diluted share) and Adjusted EBITDA of $16.1 million, a 15.5% increase. Viemed also updated its full-year 2025 financial guidance, narrowing the net revenue expectation to $271 million to $273 million and Adjusted EBITDA to $60 million to $62 million, reflecting strong operational performance and strategic growth initiatives including the acquisition of Lehan's Medical Equipment.
Stonegate Capital Partners Initiates Coverage on Viemed Healthcare, Inc. (VMD)
Stonegate Capital Partners has initiated coverage on Viemed Healthcare, Inc. (NASDAQ: VMD), a leading U.S. provider of in-home post-acute respiratory care. Viemed specializes in non-invasive ventilation for COPD and chronic respiratory failure, demonstrating 15 consecutive quarters of organic growth and strong revenue guidance. The company has diversified its services to include sleep therapy, oxygen therapy, staffing, and maternity care.
Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results
Viemed Healthcare, Inc. has announced the completion of its acquisition of Illinois-based Lehan’s Medical Equipment for a base price of $26 million, plus estimated contingent payments of $2.2 million. The acquisition, funded by cash and credit facilities, is expected to enhance Viemed's market presence and service offerings in respiratory and women's health equipment. Viemed plans to update its full-year 2025 financial guidance to reflect this new contribution when it reports Q2 2025 earnings.
Viemed Healthcare Announces Third Quarter 2025 Financial Results
Viemed Healthcare, Inc. reported record net revenues of $71.9 million for Q3 2025, a 24% increase year-over-year, and net income of $3.5 million. The company also completed a share repurchase program and acquired Lehan’s Medical Equipment, contributing to expanded patient counts and updated full-year 2025 financial guidance.
(VMD) Volatility Zones as Tactical Triggers
This article provides a detailed analysis of Viemed Healthcare Inc. (NYSE: VMD) using AI models, highlighting stable neutral readings in shorter horizons and testing resistance. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal analysis and encourages access to real-time signals for institutional-grade insights.
Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results
Viemed Healthcare, Inc. has announced the completion of its acquisition of Lehan’s Medical Equipment for a base purchase price of $26 million, plus estimated contingent payments. This acquisition combines Lehan's established market presence and specialized services with Viemed's national scale, enhancing their reach in respiratory healthcare and women's health. Viemed plans to update its full-year 2025 financial guidance to reflect the expected contributions from this acquisition following its second-quarter 2025 earnings report.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via a provided dial-in number or live audio webcast. A replay will be available on the company's investor relations website.
Viemed Healthcare (NASDAQ:VMD) investors are sitting on a loss of 11% if they invested a year ago
Viemed Healthcare (NASDAQ:VMD) investors have experienced an 11% loss over the last year, underperforming the broader market. Despite this, the company's earnings per share (EPS) improved during the same period, suggesting that growth expectations might have been overly optimistic in the past. Viemed Healthcare also managed to grow its revenue, indicating a potential market overreaction to the stock's performance.
Viemed Healthcare (NASDAQ:VMD) investors are sitting on a loss of 11% if they invested a year ago
Viemed Healthcare (NASDAQ:VMD) shareholders have experienced an 11% loss over the past year, significantly underperforming the broader market. Despite this share price decline, the company's earnings per share (EPS) actually improved, suggesting that market sentiment may have previously had unreasonable growth expectations. Revenue also grew in the last year, indicating potential for a market overreaction that could present an opportunity for investors.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can join via dialing a toll-free number or an international number, and a live audio webcast will also be available. A replay will be accessible on the Company's Investor Relations website following the call.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare Inc. (NASDAQ:VMD) has announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via dialing into the call or by live audio webcast. A replay will be available on the company’s website following the call.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can join the call via dialing or a live audio webcast, with a replay available on the company’s website. Viemed is a national leader in in-home, technology-enabled post-acute respiratory care.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via a provided dial-in number or live audio webcast, with a replay available on the Company's investor relations website afterward. Viemed Healthcare is a leader in in-home, technology-enabled post-acute respiratory care in the United States.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can join the call via phone or live audio webcast, with a replay available afterward on the company's investor relations website. Viemed Healthcare is a leader in in-home, technology-enabled post-acute respiratory care in the United States.
Viemed Healthcare Announces Completion of Share Repurchase Program
Viemed Healthcare, Inc. (NASDAQ:VMD) announced the completion of its previously authorized share repurchase program, repurchasing all 1,976,441 common shares for approximately $13.2 million. The company's CEO, Casey Hoyt, stated that this action reflects confidence in Viemed’s long-term outlook and commitment to enhancing shareholder value, supported by a strong balance sheet and increasing free cash flow. Viemed plans to continue investing in growth opportunities while returning capital to shareholders.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, a national leader in in-home post-acute respiratory care, has announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via domestic or international dial-in numbers or a live audio webcast. A replay will be available on the company's investor relations website following the call.
Viemed Healthcare Announces Completion of Share Repurchase Program
Viemed Healthcare, Inc. (NASDAQ: VMD) has officially completed its previously announced share repurchase program, buying back all 1,976,441 authorized common shares. This initiative, which cost approximately $13.2 million at a weighted average price of $6.69 per share, demonstrates the company's confidence in its future and its commitment to enhancing shareholder value. CEO Casey Hoyt highlighted the company's strong balance sheet and increasing free cash flow as drivers for continued investment in growth and capital returns to shareholders.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can join via dialing a US toll-free or international number, or through a live audio webcast. A replay will be available on the company's Investor Relations website following the call.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via a toll-free number, an international number, or a live audio webcast. A replay of the call will be available on the company's investor relations website.
Viemed Healthcare Announces Completion of Share Repurchase Program
Viemed Healthcare, Inc. announced the completion of its previously authorized share repurchase program, buying back 1,976,441 common shares for approximately $13.2 million. This represents about 5% of the total issued and outstanding shares at the time of authorization. CEO Casey Hoyt emphasized that this completion demonstrates the company's confidence in its long-term outlook and commitment to enhancing shareholder value.
Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. announced it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT. Interested parties can participate by dialing provided numbers or via live audio webcast. A replay will be available on the company's website after the call.
Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. announced it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT. Interested parties can participate via a US toll-free number, an international number, or a live audio webcast. A replay will be available on the company’s investor relations website.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. The call will discuss their financial results for the third quarter of 2025. Interested parties can participate via a dial-in number or a live audio webcast, with a replay available on their investor relations website.
Viemed Healthcare Announces Third Quarter 2025 Financial Results - Press Connects | Press & Sun-Bulletin
Viemed Healthcare, Inc. (NASDAQ:VMD) announced strong financial results for the third quarter of 2025, reporting record net revenues of $71.9 million, a 24.0% increase year-over-year, and a net income of $3.5 million. The company's operational highlights include the strategic acquisition of Lehan’s Medical Equipment, the repurchase of 1.7 million common shares, and significant increases in ventilator and PAP therapy patient counts. Viemed also updated its full-year 2025 guidance, expecting net revenue between $271 million and $273 million, and Adjusted EBITDA between $60 million and $62 million.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can join by dialing in or via a live audio webcast, with a replay available afterward on the company's investor relations website. Viemed is a national leader in in-home, technology-enabled post-acute respiratory care.
Viemed Healthcare Rides Acquisitions And Patient Growth To Higher Profits
Viemed Healthcare reported a 24% year-over-year revenue increase to $71.91 million in Q3, driven by patient base expansion and the acquisition of Lehans Medical, though it slightly missed analyst targets. Despite the miss, Wall Street remains optimistic, with analysts maintaining 'buy' or 'strong buy' ratings and price targets significantly above current levels. The company projects strong full-year revenue and adjusted EBITDA, highlighting its growth momentum and successful acquisition strategy in the consolidating healthcare sector.
Viemed Healthcare Announces Third Quarter 2025 Financial Results
Viemed Healthcare, Inc. announced record-setting financial results for the third quarter of 2025, with net revenues reaching $71.9 million, a 24.0% increase year-over-year. The Company reported significant growth in patient counts and completed a share repurchase program, while also updating its full-year 2025 financial guidance. Viemed's strategic acquisition of Lehan's Medical Equipment contributed to its strong financial performance and expanded market presence.
Viemed Healthcare Inc Q3 2025 Earnings: EPS Meets Estimates at $0.09, Revenue Slightly Misses at $71.9 Million
Viemed Healthcare Inc reported Q3 2025 revenue of $71.9 million, a 24.0% year-over-year increase, slightly missing the estimated $72.00 million. The company's EPS met estimates at $0.09, with a net income of $3.5 million. Strategic acquisitions and share repurchases contributed to strong operational performance despite challenges in maintaining profit margins.
Viemed Healthcare Announces Third Quarter 2025 Financial Results
Viemed Healthcare announced record financial results for the third quarter of 2025, with net revenues of $71.9 million, a 24.0% increase year-over-year. The company's net income attributable to Viemed was $3.5 million, or $0.09 per diluted share, and Adjusted EBITDA rose by 15.5% to $16.1 million. Viemed also updated its full-year 2025 financial guidance and highlighted strategic achievements including the acquisition of Lehan’s Medical Equipment and significant share repurchases.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. announced details for its Third Quarter 2025 Earnings Conference Call, scheduled for Thursday, November 6, 2025, at 11:00 a.m. ET. The call will discuss the company's financial performance and will be accessible via phone and a live audio webcast, with a replay available on their investor relations website. Viemed Healthcare is a national leader in in-home, technology-enabled post-acute respiratory care.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can access the call via dialing instructions or a live audio webcast. A replay will also be available on the company's investor relations website.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via phone or live audio webcast. A replay will be available on the company's investor relations website.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via dialing in or through a live audio webcast, with a replay available afterward on the company's investor relations website. Viemed is a national leader in in-home, technology-enabled post-acute respiratory care.
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare, Inc. (NASDAQ:VMD) has announced it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET. Interested parties can participate via a dial-in number or a live audio webcast. A replay will be available on the company's website.
Viemed Healthcare’s (VMD) “Hold (C)” Rating Reaffirmed at Weiss Ratings - Defense World
Weiss Ratings has reaffirmed Viemed Healthcare's (VMD) "Hold (C)" rating. The article details recent insider stock sales, with VP Jerome Cambre selling 4,880 shares worth $35,721.60. Additionally, several institutional investors adjusted their stakes in VMD during the second quarter, and the company's business description as a provider of home medical equipment and post-acute respiratory healthcare services is outlined.
Viemed Healthcare to Present at LD Micro Main Event XIX; CFO Trae Fitzgerald - Stock Titan
Viemed Healthcare, Inc. (NASDAQ: VMD) announced it will present at the 19th annual LD Micro Main Event XIX on October 21, 2025, at 11:00 AM PT in San Diego. CFO Trae Fitzgerald will discuss operational priorities, financial performance, and strategic direction, and management will be available for one-on-one investor meetings. The three-day conference, from October 19-21, 2025, will feature approximately 120 companies.
Viemed Healthcare Announces Completion of Share Repurchase Program
Viemed Healthcare, Inc. has completed its previously announced share repurchase program, buying back all 1,976,441 authorized common shares at a total cost of approximately $13.2 million. This move, executed through open market transactions, demonstrates the company's confidence in its long-term outlook and commitment to enhancing shareholder value. Viemed Healthcare emphasizes its strong balance sheet and liquidity, which enable investments in growth opportunities while returning capital to shareholders.
LSUE, VieMed Announce Respiratory Care Laboratory Upgrades
Louisiana State University Eunice (LSUE) and VieMed Healthcare have partnered to upgrade the respiratory care laboratory at LSUE. VieMed Healthcare invested $100,000 for renovations and equipment, including a new medical air-gas system, to enhance training for future respiratory therapists. This collaboration aims to address the growing demand for respiratory therapists and provide students with real-world experience, ensuring the continued quality of healthcare in the community.
Viemed Healthcare, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:VMD)
Viemed Healthcare, Inc. published its 2025 Q2 earnings call presentation. This article, provided by SA Transcripts, highlights the availability of the slide deck that accompanied the call. The Seeking Alpha transcripts team is responsible for compiling and publishing these financial documents.
